In conclusion, we demonstrate in this study the damaging effects of neutralizing IL-6R on intestinal epithelial homeostasis during MAP infection which may explain the lack of effective therapeutic response in many CD patients receiving anti-IL-6 based therapy. This evidence concerns the gene IL6R and Cowden disease.